SM | ||
---|---|---|
OUTLOOK RATING 1..100 | 56 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 44 Fair valued | |
PROFIT vs RISK RATING 1..100 | 30 | |
SMR RATING 1..100 | 42 | |
PRICE GROWTH RATING 1..100 | 79 | |
P/E GROWTH RATING 1..100 | 36 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ISTB | SM | |
---|---|---|
RSI ODDS (%) | 4 days ago14% | 4 days ago84% |
Stochastic ODDS (%) | 4 days ago16% | 4 days ago82% |
Momentum ODDS (%) | 4 days ago21% | 4 days ago81% |
MACD ODDS (%) | 4 days ago26% | 4 days ago75% |
TrendWeek ODDS (%) | 4 days ago26% | 4 days ago82% |
TrendMonth ODDS (%) | 4 days ago25% | 4 days ago81% |
Advances ODDS (%) | 8 days ago26% | 22 days ago79% |
Declines ODDS (%) | 19 days ago28% | 8 days ago83% |
BollingerBands ODDS (%) | 4 days ago19% | 4 days ago73% |
Aroon ODDS (%) | 4 days ago24% | 4 days ago80% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BIPIX | 71.05 | 2.25 | +3.27% |
ProFunds Biotechnology UltraSector Inv | |||
ANODX | 22.40 | 0.45 | +2.05% |
American Century Small Cap Growth R6 | |||
FAMFX | 26.96 | 0.44 | +1.66% |
FAM Small Cap Investor | |||
GFACX | 65.17 | 0.54 | +0.84% |
American Funds Growth Fund of Amer C | |||
PIDIX | 12.21 | 0.03 | +0.25% |
Principal International EQ Index Instl |
A.I.dvisor tells us that ISTB and SM have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ISTB and SM's prices will move in lockstep.
Ticker / NAME | Correlation To ISTB | 1D Price Change % | ||
---|---|---|---|---|
ISTB | 100% | +0.16% | ||
SM - ISTB | 3% Poorly correlated | +0.98% | ||
PTEN - ISTB | 2% Poorly correlated | N/A |